<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-22249" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Gilbert Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Grant</surname>
            <given-names>Lafaine M.</given-names>
          </name>
          <aff>University of Texas Southwestern Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Faust</surname>
            <given-names>Thomas W.</given-names>
          </name>
          <aff>Un of Tennessee Health Science Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Thoguluva Chandrasekar</surname>
            <given-names>Viveksandeep</given-names>
          </name>
          <aff>University of Kansas Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>John</surname>
            <given-names>Savio</given-names>
          </name>
          <aff>SUNY Upstate Medical University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Lafaine Grant declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Thomas Faust declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Viveksandeep Thoguluva Chandrasekar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Savio John declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>5</day>
          <month>10</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-22249.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Gilbert syndrome is a common genetic disorder affecting bilirubin metabolism in the liver. This autosomal recessive condition leads to mild to moderate unconjugated hyperbilirubinemia, often presenting as recurrent episodes of jaundice.&#x000a0;The prognosis for individuals with Gilbert syndrome is excellent, and the condition does not lead to significant liver disease. However, patients with Gilbert syndrome may have an increased risk of drug toxicity when exposed to medications that affect bilirubin metabolism.</p>
        <p>Patients with Gilbert syndrome typically have normal liver function tests aside from elevated unconjugated bilirubin levels. The condition is generally asymptomatic and does not require treatment, but several factors, including fasting, illness, menstruation, and dehydration, may trigger symptoms. Diagnosing Gilbert syndrome involves excluding other causes of hyperbilirubinemia.&#x000a0;</p>
        <p>This activity for healthcare professionals reviews the etiology, epidemiology, pathophysiology, clinical presentation, recommended evaluation, and management of Gilbert syndrome and highlights the role of the interprofessional team in improving the quality of life and outcomes for patients with this genetic disorder.&#x000a0;</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the clinical signs and triggers of mild unconjugated hyperbilirubinemia in patients with Gilbert syndrome.</p></list-item><list-item><p>Differentiate Gilbert syndrome from other causes of jaundice and hyperbilirubinemia through clinical and laboratory assessment.</p></list-item><list-item><p>Implement a targeted diagnostic approach to rule out other hepatic disorders without overutilizing unnecessary tests.</p></list-item><list-item><p>Apply interprofessional team strategies to improve care coordination and outcomes in&#x000a0;patients with Gilbert syndrome.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22249&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22249">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-22249.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Gilbert syndrome is a common genetic disorder affecting bilirubin metabolism in the liver. This condition, described in the early 1900s by Gilbert, Castaigne, and Lereboulette, is an autosomal recessive disorder that is a frequent cause of mild-to-moderate isolated unconjugated hyperbilirubinemia.&#x000a0;The prevalence of Gilbert syndrome ranges from 2% to 20%, depending on an individual's ethnicity.<xref ref-type="bibr" rid="article-22249.r1">[1]</xref><xref ref-type="bibr" rid="article-22249.r2">[2]</xref>&#x000a0;Reduced glucuronidation of bilirubin leads to unconjugated hyperbilirubinemia and recurrent episodes of jaundice.<xref ref-type="bibr" rid="article-22249.r1">[1]</xref>&#x000a0;Under normal circumstances, approximately 95% of bilirubin is unconjugated.&#x000a0;Gilbert syndrome does not require treatment but must be distinguished from other disorders&#x000a0;of unconjugated hyperbilirubinemia.<xref ref-type="bibr" rid="article-22249.r3">[3]</xref>&#x000a0;</p>
        <p>Various diagnoses should be considered when evaluating patients with unconjugated hyperbilirubinemia, including disorders of bilirubin uptake, conjugation, and overproduction (see <bold>Image</bold>. Metabolic Pathway for Bilirubin in the Hepatocyte).<xref ref-type="bibr" rid="article-22249.r4">[4]</xref>&#x000a0;Disorders of hepatic uptake, storage, conjugation, and excretion can cause unconjugated and conjugated hyperbilirubinemia.&#x000a0;Crigler-Najjar syndrome is characterized by marked unconjugated hyperbilirubinemia.<xref ref-type="bibr" rid="article-22249.r5">[5]</xref>&#x000a0;Moreover, hemolytic reactions, ineffective erythropoiesis, and resorbing hematomas induce bilirubin overproduction and subsequent unconjugated hyperbilirubinemia. Hemolytic reactions include but are not limited to hereditary enzyme deficiencies, hemoglobinopathies, red blood cell membrane defects, infections, medications, toxins, warm autoimmune hemolytic anemia, paroxysmal cold hemoglobinuria, and cold agglutinin disease that can lead to elevated unconjugated bilirubin levels.<xref ref-type="bibr" rid="article-22249.r6">[6]</xref><xref ref-type="bibr" rid="article-22249.r7">[7]</xref> Most patients with Gilbert syndrome are asymptomatic regarding liver disease, but they may express symptoms related to triggers. Triggers that can precipitate unconjugated hyperbilirubinemia of Gilbert syndrome include but are not limited to fasting, intercurrent illness, menstruation, and dehydration.<xref ref-type="bibr" rid="article-22249.r3">[3]</xref></p>
        <p>Other acute and chronic liver diseases typically present&#x000a0;with unconjugated and conjugated hyperbilirubinemia.<xref ref-type="bibr" rid="article-22249.r8">[8]</xref>&#x000a0;With hepatobiliary disorders, the proportion of conjugated bilirubin rises. Consequently,&#x000a0;consideration of viral, metabolic, and autoimmune&#x000a0;disorders of the liver is necessary when evaluating patients with hyperbilirubinemia and jaundice. Careful clinical assessment, targeted laboratory evaluation, and exclusion of other differential diagnoses associated with unconjugated hyperbilirubinemia, including other acute and chronic liver diseases, should be performed before diagnosing Gilbert syndrome. After diagnosing Gilbert syndrome, treatment is conservative with observation alone.<xref ref-type="bibr" rid="article-22249.r3">[3]</xref> The prognosis of patients with Gilbert syndrome is excellent.<xref ref-type="bibr" rid="article-22249.r9">[9]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-22249.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>A variety of triggers can precipitate unconjugated hyperbilirubinemia and jaundice in patients with Gilbert syndrome. Fasting, hemolytic reactions, febrile illnesses, menstruation, and physical exertion are common precipitants.<xref ref-type="bibr" rid="article-22249.r3">[3]</xref><xref ref-type="bibr" rid="article-22249.r10">[10]</xref>&#x000a0;Reducing the daily caloric intake to 400 kcal can lead to a 2- to 3-fold increase in bilirubin within 48 hours.<xref ref-type="bibr" rid="article-22249.r10">[10]</xref><xref ref-type="bibr" rid="article-22249.r11">[11]</xref>&#x000a0;Moreover, a similar rise in bilirubin can&#x000a0;present with an average-calorie diet without lipid supplementation.<xref ref-type="bibr" rid="article-22249.r12">[12]</xref>&#x000a0;</p>
        <p>The bilirubin value typically returns to normal within 12 to 24 hours with a normal diet.&#x000a0;Several theories have been proposed to explain unconjugated hyperbilirubinemia following dietary manipulation, including increased cycling of bilirubin by the enterohepatic circulation, decreased conjugation due to decreased levels of uridine 5'-diphospho-glucuronosyltransferase-glucuronic acid, a cosubstrate in glucuronidation, and&#x000a0;release of bilirubin from fat cells.<xref ref-type="bibr" rid="article-22249.r13">[13]</xref><xref ref-type="bibr" rid="article-22249.r14">[14]</xref><xref ref-type="bibr" rid="article-22249.r15">[15]</xref></p>
      </sec>
      <sec id="article-22249.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Gilbert syndrome has a prevalence rate between 4% and 16%, but this can vary depending on ethnic ancestry.<xref ref-type="bibr" rid="article-22249.r16">[16]</xref><xref ref-type="bibr" rid="article-22249.r17">[17]</xref><xref ref-type="bibr" rid="article-22249.r18">[18]</xref>&#x000a0;In the White population, the prevalence of Gilbert syndrome has been estimated to be 2% to 10%. Japan and East Asia have a prevalence of about 2%, while India, Southern Asia, and the Middle East have rates of up to 20%.<xref ref-type="bibr" rid="article-22249.r19">[19]</xref>&#x000a0;Clinical manifestations are characteristically present during early adolescence and are more frequently found in men.<xref ref-type="bibr" rid="article-22249.r20">[20]</xref>&#x000a0;Most likely, differences in sex steroid concentrations and higher bilirubin production in males account for higher prevalence rates.<xref ref-type="bibr" rid="article-22249.r20">[20]</xref>&#x000a0;Most cases are diagnosed around puberty due to higher hemoglobin turnover and endogenous steroid hormone-induced inhibition of bilirubin glucuronidation.<xref ref-type="bibr" rid="article-22249.r20">[20]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-22249.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Gilbert syndrome is inherited in an autosomal recessive manner. In the White population, Gilbert syndrome is most commonly associated with the homozygous polymorphism <italic toggle="yes">A(TA)<sub>7</sub>TAA</italic> in the promoter region of&#x000a0;<italic toggle="yes">UGT1A1</italic>&#x000a0;(uridine diphosphoglucoronate-glucuronosyltransferase 1A1), which leads to a significant reduction in the glucuronidation of bilirubin. Homozygosity for a defect in the TATA box within the promoter region of&#x000a0;<italic toggle="yes">UGT1A1</italic> leads to a mutation of <italic toggle="yes">UGT1A1</italic> called UGT1A1*28. The molecular defect inserts an additional dinucleotide sequence (TA) into the transcription initiation sequence: <italic toggle="yes">A(TA)<sub>6</sub>TAA</italic> to <italic toggle="yes">A(TA)<sub>7</sub>TAA</italic>.<xref ref-type="bibr" rid="article-22249.r1">[1]</xref>&#x000a0;<italic toggle="yes">UGT1A1</italic> activity is only 30% to 50% normal in patients with Gilbert syndrome.<xref ref-type="bibr" rid="article-22249.r21">[21]</xref>&#x000a0;</p>
        <p>Monoconjugated bile pigments are increased by 34% in this patient group.<xref ref-type="bibr" rid="article-22249.r21">[21]</xref>&#x000a0;Patients who are heterozygous for the mutation have serum bilirubin values higher than the normal population. Not all patients who are homozygous with a promoter mutation will develop Gilbert syndrome, as other factors (eg, male or female sex) may be important for clinical expression.<xref ref-type="bibr" rid="article-22249.r22">[22]</xref><xref ref-type="bibr" rid="article-22249.r23">[23]</xref><xref ref-type="bibr" rid="article-22249.r24">[24]</xref>&#x000a0;Individuals of Asian ancestry with Gilbert syndrome are much less likely to have the UG1A1*28 mutation. Rather, decreased expression of <italic toggle="yes">UGT1A1</italic> is thought to be due to variants in the coding regions of the gene.</p>
        <p>Gilbert syndrome represents a spectrum of disease activity, as represented by impaired <italic toggle="yes">UGT1A1</italic> activity. More than 100 mutations have been associated with Gilbert Syndrome, with different frequencies noted in different ethnic groups. This is also why genetic testing should not be used to diagnose Gilbert syndrome definitively.</p>
      </sec>
      <sec id="article-22249.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>A liver biopsy is generally not required for patients suspected of having Gilbert syndrome unless other confounding diagnoses&#x000a0;merit consideration. A liver biopsy, if done, will show normal histology. Nonspecific lipofuscin pigment found within the centrilobular region of the biopsy has also been described.<xref ref-type="bibr" rid="article-22249.r25">[25]</xref><xref ref-type="bibr" rid="article-22249.r26">[26]</xref></p>
      </sec>
      <sec id="article-22249.s7" sec-type="Toxicokinetics">
        <title>Toxicokinetics</title>
        <p><italic toggle="yes">UGT1A1</italic>&#x000a0;is involved in the metabolism of estrogen and several other drugs through glucuronidation. Hence, individuals with Gilbert syndrome may be susceptible to toxicities from&#x000a0;medications that require glucuronidation. Irinotecan is well-known&#x000a0;to cause toxicity in patients with Gilbert syndrome.<xref ref-type="bibr" rid="article-22249.r27">[27]</xref><xref ref-type="bibr" rid="article-22249.r28">[28]</xref> The active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38) accumulates and can cause diarrhea and myelosuppression. Antiviral agents atazanavir and indinavir&#x000a0;inhibit <italic toggle="yes">UGT1A1</italic>&#x000a0;and may cause hyperbilirubinemia.<xref ref-type="bibr" rid="article-22249.r29">[29]</xref><xref ref-type="bibr" rid="article-22249.r29">[29]</xref>&#x000a0;Other drugs that suppress or compete with <italic toggle="yes">UGT1A1 </italic>activity include but are not limited to, acetaminophen, tyrosine kinase inhibitors, nonsteroidal anti-inflammatory drugs, statins, ezetimibe, oxazepam, lorazepam, lamotrigine, cyclosporin A, rifampin, ethinylestradiol, buprenorphine, menthol, and tocilizumab.<xref ref-type="bibr" rid="article-22249.r30">[30]</xref><xref ref-type="bibr" rid="article-22249.r31">[31]</xref><xref ref-type="bibr" rid="article-22249.r32">[32]</xref><xref ref-type="bibr" rid="article-22249.r23">[23]</xref></p>
      </sec>
      <sec id="article-22249.s8" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Gilbert syndrome typically appears during adolescence.<xref ref-type="bibr" rid="article-22249.r20">[20]</xref> Males are more commonly affected than females in a 3:1 ratio.<xref ref-type="bibr" rid="article-22249.r20">[20]</xref>&#x000a0;Except for mild jaundice, patients are usually asymptomatic from liver disease but may have complaints attributable to the triggers outlined above.<xref ref-type="bibr" rid="article-22249.r3">[3]</xref><xref ref-type="bibr" rid="article-22249.r10">[10]</xref> Patients with Gilbert syndrome have an increased incidence of pigmented gallstones.<xref ref-type="bibr" rid="article-22249.r33">[33]</xref><xref ref-type="bibr" rid="article-22249.r34">[34]</xref><xref ref-type="bibr" rid="article-22249.r35">[35]</xref> Underlying hemolytic reactions result in bilirubin overproduction and may cause unconjugated hyperbilirubinemia.<xref ref-type="bibr" rid="article-22249.r6">[6]</xref><xref ref-type="bibr" rid="article-22249.r7">[7]</xref>&#x000a0;</p>
        <p>When evaluating a patient for Gilbert Syndrome, clinicians should obtain a detailed drug history to assess for drug-induced liver injury and to evaluate for drugs that suppress hepatic bilirubin metabolism, family history given the inheritance pattern of Gilbert syndrome, and obtain laboratory records, if available to identify patients with a history of prior intermittent episodes of isolated indirect hyperbilirubinemia. Clinicians should also&#x000a0;consider other acute and chronic liver diseases based on the history and physical examination. Patients with elevated liver enzymes or incidental hepatic steatosis noted on imaging should be evaluated for metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH). Key factors that can predispose a patient to MASLD/MASH include diabetes, hypertension, obesity, and hyperlipidemia, as well as genetic risk factors such as genetic variants in&#x000a0;<italic toggle="yes">PNPLA3</italic>, which is most commonly seen in Hispanic individuals.</p>
        <p>Patients should be questioned about a history of significant alcohol use, which can lead to alcohol-related hepatitis and metabolic-alcohol-associated liver disease. Additionally, a history of&#x000a0;intravenous drug use, blood transfusions, incarceration, tattoos, country of birth,&#x000a0;and high-risk sexual activity should be obtained, which may suggest either hepatitis B or C.<xref ref-type="bibr" rid="article-22249.r36">[36]</xref><xref ref-type="bibr" rid="article-22249.r37">[37]</xref>&#x000a0;A careful history&#x000a0;of autoimmune diseases in the patient or family may suggest a consideration of primary biliary cholangitis, primary sclerosing cholangitis, or autoimmune hepatitis.<xref ref-type="bibr" rid="article-22249.r38">[38]</xref>&#x000a0;Patients with isolated Gilbert syndrome should not have any evidence of clinically significant portal hypertension or hepatic decompensation, as manifested by&#x000a0;varices, ascites, or hepatic encephalopathy.</p>
      </sec>
      <sec id="article-22249.s9" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Gilbert syndrome is associated with an isolated unconjugated hyperbilirubinemia with a serum total bilirubin below 4 mg/dL. However, the bilirubin level can fluctuate depending on exacerbating factors.<xref ref-type="bibr" rid="article-22249.r3">[3]</xref> Characteristically, patients will have a normal complete blood count, reticulocyte count, lactate dehydrogenase, and peripheral smear&#x000a0;supportive of the absence of hemolysis.<xref ref-type="bibr" rid="article-22249.r19">[19]</xref>&#x000a0;The aminotransferases and alkaline phosphatase are normal.<xref ref-type="bibr" rid="article-22249.r39">[39]</xref><xref ref-type="bibr" rid="article-22249.r40">[40]</xref><xref ref-type="bibr" rid="article-22249.r41">[41]</xref>&#x000a0;</p>
        <p>Diagnostic imaging of the liver and biliary tree&#x000a0;is generally not required unless the clinician is considering another diagnosis. As previously discussed, liver biopsy is rarely indicated unless the clinician suspects another acute or chronic liver disorder. Provocative testing with a 48-hour fast or with medications such as nicotinic acid, phenobarbital, or rifampin is no longer routinely used or recommended.</p>
        <p>Genetic testing with assays of <italic toggle="yes">UGT1A1</italic> activity and polymerase chain reaction to identify gene polymorphisms in the TATA box of <italic toggle="yes">UGT1A1</italic>&#x000a0;can be considered&#x000a0;in cases of diagnostic uncertainty when starting drugs that may affect <italic toggle="yes">UGT1A1</italic> activity&#x000a0;(Please refer to the <bold>Toxicokinetics</bold>&#x000a0;section for more information on these medications)&#x000a0;or when family counseling is essential.<xref ref-type="bibr" rid="article-22249.r17">[17]</xref>&#x000a0;If the patient is found to have elevated serum liver biochemistries, studies should be sent to evaluate for&#x000a0;chronic viral hepatitis, autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, Wilson disease, hemochromatosis, celiac disease, thyroid abnormalities, and alpha-1 antitrypsin deficiency.<xref ref-type="bibr" rid="article-22249.r36">[36]</xref><xref ref-type="bibr" rid="article-22249.r42">[42]</xref><xref ref-type="bibr" rid="article-22249.r43">[43]</xref><xref ref-type="bibr" rid="article-22249.r44">[44]</xref></p>
      </sec>
      <sec id="article-22249.s10" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Patients with Gilbert syndrome do not require treatment.<xref ref-type="bibr" rid="article-22249.r3">[3]</xref>&#x000a0;Therefore, management primarily consists of reassuring patients and their families that this is a benign condition that does not require further testing. However, patients, family members, and clinicians should be counseled that individuals with Gilbert syndrome may be at an increased risk of drug toxicity when exposed to medications that suppress or affect <italic toggle="yes">UGT1A1 </italic>activity (Please refer to the&#x000a0;<bold>Toxicokinetics</bold>&#x000a0;section for more information on these medications).<xref ref-type="bibr" rid="article-22249.r23">[23]</xref></p>
      </sec>
      <sec id="article-22249.s11" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>
<bold>Unconjugated Hyperbilirubinemia</bold>
</p>
        <p>Differential diagnoses that should be considered with various causes of unconjugated hyperbilirubinemia include:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Increased bilirubin production</bold>: Extravascular and intravascular hemolysis, resorbing hematoma, dyseryrthopoiesis, Wilson disease</p>
          </list-item>
          <list-item>
            <p><bold>Impaired hepatic bilirubin uptake</bold>:<bold>&#x000a0;</bold>Heart failure, portosystemic shunts, Gilbert syndrome, medications</p>
          </list-item>
          <list-item>
            <p><bold>Impaired bilirubin conjugation</bold>:<bold>&#x000a0;</bold>Gilbert syndrome, Crigler-Najjar syndrome types I and II, advanced liver disease&#x000a0;<xref ref-type="bibr" rid="article-22249.r45">[45]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Conjugated Hyperbilirubinemia</bold>
</p>
        <p>Differential diagnoses that should be considered with various causes of conjugated hyperbilirubinemia include:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Defects of canalicular organic anion transport</bold>:<bold>&#x000a0;</bold>Dubin-Johnson syndrome</p>
          </list-item>
          <list-item>
            <p><bold>Defects of sinusoidal reuptake of conjugated bilirubin</bold>:<bold>&#x000a0;</bold>Rotor syndrome</p>
          </list-item>
          <list-item>
            <p><bold>Extrahepatic cholestasis: </bold>Choledocholithiasis, pancreaticobiliary malignancy, primary sclerosing cholangitis, pancreatitis, parasitic infection</p>
          </list-item>
          <list-item>
            <p><bold>Intrahepatic cholestasis</bold>:<bold>&#x000a0;</bold>Viral hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease, primary biliary cholangitis, drugs and toxins, sepsis, infiltrative diseases, parenteral nutrition, sickle cell disease, pregnancy, end-stage liver disease&#x000a0;<xref ref-type="bibr" rid="article-22249.r45">[45]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22249.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Patients with Gilbert syndrome have an excellent prognosis.<xref ref-type="bibr" rid="article-22249.r3">[3]</xref> Outcomes of patients with Gilbert syndrome are similar to that of the general population. The possible beneficial effects of mild unconjugated hyperbilirubinemia include a lower incidence of atherosclerosis,&#x000a0;increased insulin sensitivity, decreased risk of metabolic syndrome and obesity, as well as a lower incidence of autoimmune diseases, endometrial cancer, Hodgkin lymphoma, and cancer-related mortality.<xref ref-type="bibr" rid="article-22249.r3">[3]</xref><xref ref-type="bibr" rid="article-22249.r23">[23]</xref><xref ref-type="bibr" rid="article-22249.r3">[3]</xref><xref ref-type="bibr" rid="article-22249.r30">[30]</xref><xref ref-type="bibr" rid="article-22249.r46">[46]</xref></p>
      </sec>
      <sec id="article-22249.s13" sec-type="Complications">
        <title>Complications</title>
        <p>Gilbert syndrome is a benign, autosomal recessive inherited disorder of bilirubin metabolism.<xref ref-type="bibr" rid="article-22249.r3">[3]</xref> Patients are at an increased risk for more severe drug interactions, the development of pigmented gallstones, and more severe jaundice during the neonatal age, as well as in individuals with coexisting hemolytic diseases.<xref ref-type="bibr" rid="article-22249.r23">[23]</xref>&#x000a0;Patients with this disease are not at risk for progressive liver disease, hepatic decompensation, or liver-related mortality.<xref ref-type="bibr" rid="article-22249.r3">[3]</xref>&#x000a0;Patients and their families should be informed of the disease's inherited and benign nature, and unnecessary testing should be avoided. If there is clinical suspicion of either acute or chronic liver disease based on the clinical presentation or laboratory studies, a more thorough evaluation should be undertaken for viral, metabolic, and autoimmune liver diseases.</p>
      </sec>
      <sec id="article-22249.s14" sec-type="Consultations">
        <title>Consultations</title>
        <p>Primary care clinicians and associated healthcare professionals can diagnose and&#x000a0;monitor&#x000a0;patients with Gilbert syndrome.<xref ref-type="bibr" rid="article-22249.r47">[47]</xref>&#x000a0;If the diagnosis is disputed&#x000a0;or patients present with findings suggestive of another liver disease, they should be referred to&#x000a0;a liver disease specialist&#x000a0;for additional evaluation and treatment.</p>
      </sec>
      <sec id="article-22249.s15" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with Gilbert syndrome should be informed about potential triggers such as fasting, intercurrent illness, menstruation, overexertion, hemolytic reactions, and dehydration that may cause a rise in unconjugated bilirubin.<xref ref-type="bibr" rid="article-22249.r10">[10]</xref><xref ref-type="bibr" rid="article-22249.r47">[47]</xref>&#x000a0;Avoidance of triggers may be advantageous to reduce anxiety about abnormal bilirubin values. Patients and their families should be&#x000a0;aware&#x000a0;of the benign nature of the disorder and its inheritance pattern and that no treatment is&#x000a0;necessary; they should also be informed about the excellent prognosis of Gilbert syndrome.</p>
      </sec>
      <sec id="article-22249.s16" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Gilbert syndrome is a benign, inherited disorder of bilirubin metabolism without the risk of progressive liver disease, hepatic decompensation, or increased mortality. However, these patients are at increased risk from drug toxicity when exposed to medications that suppress or affect <italic toggle="yes">UGT1A1</italic> activity. Unnecessary testing should be avoided, and patients should be followed conservatively. Moreover, patients with this disorder may benefit from the enhanced cardioprotective and antineoplastic effects seen with mild elevations in plasma bilirubin levels.</p>
      </sec>
      <sec id="article-22249.s17" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Gilbert syndrome may be encountered by primary care clinicians, advanced practice clinicians, emergency department clinicians, and other healthcare professionals, including pediatric, gastroenterology, or hepatology clinicians.<xref ref-type="bibr" rid="article-22249.r47">[47]</xref>&#x000a0;Healthcare personnel should be informed about the benign nature of this disorder and its excellent prognosis. Appropriate and targeted diagnostic testing should be carried out,&#x000a0;and inappropriate testing should be avoided.</p>
        <p>Patients&#x000a0;whose clinical examination or tests&#x000a0;suggest another liver disease or hepatic decompensation should be referred to a gastroenterologist or hepatologist. As with any patient encounter, high-quality, patient-centered care is necessary. Careful communication among all clinicians to streamline care should be paramount to enhance patient satisfaction and outcomes.</p>
      </sec>
      <sec id="article-22249.s18">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22249&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22249">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/gilbert-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=22249">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/22249/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=22249">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-22249.s19">
        <fig id="article-22249.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Metabolic Pathway for Bilirubin in the Hepatocyte. Bilirubin-G corresponds to bilirubin glucuronate; the donor is uridine diphosphate glucuronic acid (UDP-GA). This is catalyzed by the enzyme uridine diphosphate-glucuronyltransferase (UGT1A1). Gilbert and Crigler-Najjar syndrome is associated with decreases in UGT1A1 activity. Glutathione-S-transferase (GST) is a carrier protein that assists bilirubin uptake into the cytosol and may be implicated in Rotor syndrome. Contributed by R Kabir, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Kabir_Rotor__Syndrome" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-22249.s20">
        <title>References</title>
        <ref id="article-22249.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bosma</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Inherited disorders of bilirubin metabolism.</article-title>
            <source>J Hepatol</source>
            <year>2003</year>
            <month>Jan</month>
            <volume>38</volume>
            <issue>1</issue>
            <fpage>107</fpage>
            <page-range>107-17</page-range>
            <pub-id pub-id-type="pmid">12480568</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burchell</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hume</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Molecular genetic basis of Gilbert's syndrome.</article-title>
            <source>J Gastroenterol Hepatol</source>
            <year>1999</year>
            <month>Oct</month>
            <volume>14</volume>
            <issue>10</issue>
            <fpage>960</fpage>
            <page-range>960-6</page-range>
            <pub-id pub-id-type="pmid">10530490</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fretzayas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moustaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Liapi</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Karpathios</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Gilbert syndrome.</article-title>
            <source>Eur J Pediatr</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>171</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <page-range>11-5</page-range>
            <pub-id pub-id-type="pmid">22160004</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Erlinger</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Arias</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Dhumeaux</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Inherited disorders of bilirubin transport and conjugation: new insights into molecular mechanisms and consequences.</article-title>
            <source>Gastroenterology</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>146</volume>
            <issue>7</issue>
            <fpage>1625</fpage>
            <page-range>1625-38</page-range>
            <pub-id pub-id-type="pmid">24704527</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strauss</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Ahlfors</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Soltys</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mazareigos</surname>
                <given-names>GV</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bowser</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Fox</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Squires</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>McKiernan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Brigatti</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Puffenberger</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Carson</surname>
                <given-names>VJ</given-names>
              </name>
              <name>
                <surname>Vreman</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Crigler-Najjar Syndrome Type 1: Pathophysiology, Natural History, and Therapeutic Frontier.</article-title>
            <source>Hepatology</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>71</volume>
            <issue>6</issue>
            <fpage>1923</fpage>
            <page-range>1923-1939</page-range>
            <pub-id pub-id-type="pmid">31553814</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muraca</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fevery</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Blanckaert</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Relationships between serum bilirubins and production and conjugation of bilirubin. Studies in Gilbert's syndrome, Crigler-Najjar disease, hemolytic disorders, and rat models.</article-title>
            <source>Gastroenterology</source>
            <year>1987</year>
            <month>Feb</month>
            <volume>92</volume>
            <issue>2</issue>
            <fpage>309</fpage>
            <page-range>309-17</page-range>
            <pub-id pub-id-type="pmid">3792767</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muraca</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Blanckaert</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Liquid-chromatographic assay and identification of mono- and diester conjugates of bilirubin in normal serum.</article-title>
            <source>Clin Chem</source>
            <year>1983</year>
            <month>Oct</month>
            <volume>29</volume>
            <issue>10</issue>
            <fpage>1767</fpage>
            <page-range>1767-71</page-range>
            <pub-id pub-id-type="pmid">6616822</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kwo</surname>
                <given-names>PY</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.</article-title>
            <source>Am J Gastroenterol</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>112</volume>
            <issue>1</issue>
            <fpage>18</fpage>
            <page-range>18-35</page-range>
            <pub-id pub-id-type="pmid">27995906</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Horsfall</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Nazareth</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Pereira</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Petersen</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Gilbert's syndrome and the risk of death: a population-based cohort study.</article-title>
            <source>J Gastroenterol Hepatol</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>28</volume>
            <issue>10</issue>
            <fpage>1643</fpage>
            <page-range>1643-7</page-range>
            <pub-id pub-id-type="pmid">23701650</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Felsher</surname>
                <given-names>BF</given-names>
              </name>
              <name>
                <surname>Rickard</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Redeker</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <article-title>The reciprocal relation between caloric intake and the degree of hyperbilirubinemia in Gilbert's syndrome.</article-title>
            <source>N Engl J Med</source>
            <year>1970</year>
            <month>Jul</month>
            <day>23</day>
            <volume>283</volume>
            <issue>4</issue>
            <fpage>170</fpage>
            <page-range>170-2</page-range>
            <pub-id pub-id-type="pmid">5424007</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barrett</surname>
                <given-names>PV</given-names>
              </name>
            </person-group>
            <article-title>Hyperbilirubinemia of fasting.</article-title>
            <source>JAMA</source>
            <year>1971</year>
            <month>Sep</month>
            <day>06</day>
            <volume>217</volume>
            <issue>10</issue>
            <fpage>1349</fpage>
            <page-range>1349-53</page-range>
            <pub-id pub-id-type="pmid">5109641</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gollan</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Bateman</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Billing</surname>
                <given-names>BH</given-names>
              </name>
            </person-group>
            <article-title>Effect of dietary composition on the unconjugated hyperbilirubinaemia of Gilbert's syndrome.</article-title>
            <source>Gut</source>
            <year>1976</year>
            <month>May</month>
            <volume>17</volume>
            <issue>5</issue>
            <fpage>335</fpage>
            <page-range>335-40</page-range>
            <pub-id pub-id-type="pmid">1278716</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Felsher</surname>
                <given-names>BF</given-names>
              </name>
              <name>
                <surname>Carpio</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>VanCouvering</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Effect of fasting and phenobarbital on hepatic UDP-glucuronic acid formation in the rat.</article-title>
            <source>J Lab Clin Med</source>
            <year>1979</year>
            <month>Mar</month>
            <volume>93</volume>
            <issue>3</issue>
            <fpage>414</fpage>
            <page-range>414-27</page-range>
            <pub-id pub-id-type="pmid">107254</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kotal</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>V&#x000ed;tek</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fevery</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Fasting-related hyperbilirubinemia in rats: the effect of decreased intestinal motility.</article-title>
            <source>Gastroenterology</source>
            <year>1996</year>
            <month>Jul</month>
            <volume>111</volume>
            <issue>1</issue>
            <fpage>217</fpage>
            <page-range>217-23</page-range>
            <pub-id pub-id-type="pmid">8698202</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brink</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>M&#x000e9;ndez-S&#x000e1;nchez</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Carey</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Bilirubin cycles enterohepatically after ileal resection in the rat.</article-title>
            <source>Gastroenterology</source>
            <year>1996</year>
            <month>Jun</month>
            <volume>110</volume>
            <issue>6</issue>
            <fpage>1945</fpage>
            <page-range>1945-57</page-range>
            <pub-id pub-id-type="pmid">8964422</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raijmakers</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Jansen</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Steegers</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Peters</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>Association of human liver bilirubin UDP-glucuronyltransferase activity with a polymorphism in the promoter region of the UGT1A1 gene.</article-title>
            <source>J Hepatol</source>
            <year>2000</year>
            <month>Sep</month>
            <volume>33</volume>
            <issue>3</issue>
            <fpage>348</fpage>
            <page-range>348-51</page-range>
            <pub-id pub-id-type="pmid">11019988</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Borlak</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Thum</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Landt</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Erb</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hermann</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects.</article-title>
            <source>Hepatology</source>
            <year>2000</year>
            <month>Oct</month>
            <volume>32</volume>
            <issue>4 Pt 1</issue>
            <fpage>792</fpage>
            <page-range>792-5</page-range>
            <pub-id pub-id-type="pmid">11003624</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roy-Chowdhury</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Deocharan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bejjanki</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Roy-Chowdhury</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Koliopoulos</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Petmezaki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Valaes</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Presence of the genetic marker for Gilbert syndrome is associated with increased level and duration of neonatal jaundice.</article-title>
            <source>Acta Paediatr</source>
            <year>2002</year>
            <volume>91</volume>
            <issue>1</issue>
            <fpage>100</fpage>
            <page-range>100-1</page-range>
            <pub-id pub-id-type="pmid">11883809</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wagner</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Shiels</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Seyed Khoei</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bulmer</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic criteria and contributors to Gilbert's syndrome.</article-title>
            <source>Crit Rev Clin Lab Sci</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>55</volume>
            <issue>2</issue>
            <fpage>129</fpage>
            <page-range>129-139</page-range>
            <pub-id pub-id-type="pmid">29390925</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muraca</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fevery</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Influence of sex and sex steroids on bilirubin uridine diphosphate-glucuronosyltransferase activity of rat liver.</article-title>
            <source>Gastroenterology</source>
            <year>1984</year>
            <month>Aug</month>
            <volume>87</volume>
            <issue>2</issue>
            <fpage>308</fpage>
            <page-range>308-13</page-range>
            <pub-id pub-id-type="pmid">6428963</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaplan</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Gilbert's syndrome and jaundice in glucose-6-phosphate dehydrogenase deficient neonates.</article-title>
            <source>Haematologica</source>
            <year>2000</year>
            <volume>85</volume>
            <issue>E-letters</issue>
            <fpage>E01</fpage>
            <pub-id pub-id-type="pmid">11114816</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bosma</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Chowdhury</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Bakker</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gantla</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>de Boer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Oostra</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Lindhout</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tytgat</surname>
                <given-names>GN</given-names>
              </name>
              <name>
                <surname>Jansen</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Oude Elferink</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.</article-title>
            <source>N Engl J Med</source>
            <year>1995</year>
            <month>Nov</month>
            <day>02</day>
            <volume>333</volume>
            <issue>18</issue>
            <fpage>1171</fpage>
            <page-range>1171-5</page-range>
            <pub-id pub-id-type="pmid">7565971</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>V&#x000ed;tek</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tiribelli</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Gilbert's syndrome revisited.</article-title>
            <source>J Hepatol</source>
            <year>2023</year>
            <month>Oct</month>
            <volume>79</volume>
            <issue>4</issue>
            <fpage>1049</fpage>
            <page-range>1049-1055</page-range>
            <pub-id pub-id-type="pmid">37390966</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Memon</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Weinberger</surname>
                <given-names>BI</given-names>
              </name>
              <name>
                <surname>Hegyi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Aleksunes</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Inherited disorders of bilirubin clearance.</article-title>
            <source>Pediatr Res</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>79</volume>
            <issue>3</issue>
            <fpage>378</fpage>
            <page-range>378-86</page-range>
            <pub-id pub-id-type="pmid">26595536</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>SAGILD</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>DALGAARD</surname>
                <given-names>OZ</given-names>
              </name>
              <name>
                <surname>TYGSTRUP</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Constitutional hyperbilirubinemia with unconjugated bilirubin in the serum and lipochrome-like pigment granules in the liver.</article-title>
            <source>Ann Intern Med</source>
            <year>1962</year>
            <month>Feb</month>
            <volume>56</volume>
            <fpage>308</fpage>
            <page-range>308-14</page-range>
            <pub-id pub-id-type="pmid">14496018</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strassburg</surname>
                <given-names>CP</given-names>
              </name>
            </person-group>
            <article-title>Hyperbilirubinemia syndromes (Gilbert-Meulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome).</article-title>
            <source>Best Pract Res Clin Gastroenterol</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>24</volume>
            <issue>5</issue>
            <fpage>555</fpage>
            <page-range>555-71</page-range>
            <pub-id pub-id-type="pmid">20955959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iyer</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Whitington</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Roy</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Tephly</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Coffman</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Ratain</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes.</article-title>
            <source>J Clin Invest</source>
            <year>1998</year>
            <month>Feb</month>
            <day>15</day>
            <volume>101</volume>
            <issue>4</issue>
            <fpage>847</fpage>
            <page-range>847-54</page-range>
            <pub-id pub-id-type="pmid">9466980</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burchell</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Soars</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Monaghan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cassidy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ethell</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Drug-mediated toxicity caused by genetic deficiency of UDP-glucuronosyltransferases.</article-title>
            <source>Toxicol Lett</source>
            <year>2000</year>
            <month>Mar</month>
            <day>15</day>
            <volume>112-113</volume>
            <fpage>333</fpage>
            <page-range>333-40</page-range>
            <pub-id pub-id-type="pmid">10720749</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lankisch</surname>
                <given-names>TO</given-names>
              </name>
              <name>
                <surname>Moebius</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Wehmeier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Behrens</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Manns</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Strassburg</surname>
                <given-names>CP</given-names>
              </name>
            </person-group>
            <article-title>Gilbert's disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype.</article-title>
            <source>Hepatology</source>
            <year>2006</year>
            <month>Nov</month>
            <volume>44</volume>
            <issue>5</issue>
            <fpage>1324</fpage>
            <page-range>1324-32</page-range>
            <pub-id pub-id-type="pmid">17058217</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Morais</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Uetrecht</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Wells</surname>
                <given-names>PG</given-names>
              </name>
            </person-group>
            <article-title>Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome.</article-title>
            <source>Gastroenterology</source>
            <year>1992</year>
            <month>Feb</month>
            <volume>102</volume>
            <issue>2</issue>
            <fpage>577</fpage>
            <page-range>577-86</page-range>
            <pub-id pub-id-type="pmid">1732127</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carulli</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ponz de Leon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mauro</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Manenti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ferrari</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Alteration of drug metabolism in Gilbert's syndrome.</article-title>
            <source>Gut</source>
            <year>1976</year>
            <month>Aug</month>
            <volume>17</volume>
            <issue>8</issue>
            <fpage>581</fpage>
            <page-range>581-7</page-range>
            <pub-id pub-id-type="pmid">976795</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miners</surname>
                <given-names>JO</given-names>
              </name>
              <name>
                <surname>McKinnon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Mackenzie</surname>
                <given-names>PI</given-names>
              </name>
            </person-group>
            <article-title>Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance.</article-title>
            <source>Toxicology</source>
            <year>2002</year>
            <month>Dec</month>
            <day>27</day>
            <volume>181-182</volume>
            <fpage>453</fpage>
            <page-range>453-6</page-range>
            <pub-id pub-id-type="pmid">12505351</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>del Giudice</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Perrotta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nobili</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Specchia</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>d'Urzo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Iolascon</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Coinheritance of Gilbert syndrome increases the risk for developing gallstones in patients with hereditary spherocytosis.</article-title>
            <source>Blood</source>
            <year>1999</year>
            <month>Oct</month>
            <day>01</day>
            <volume>94</volume>
            <issue>7</issue>
            <fpage>2259</fpage>
            <page-range>2259-62</page-range>
            <pub-id pub-id-type="pmid">10498597</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Origa</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Galanello</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Perseu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tavazzi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Domenica Cappellini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Terenzani</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Forni</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Quarta</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Boetti</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Piga</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Cholelithiasis in thalassemia major.</article-title>
            <source>Eur J Haematol</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>82</volume>
            <issue>1</issue>
            <fpage>22</fpage>
            <page-range>22-5</page-range>
            <pub-id pub-id-type="pmid">19021734</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haverfield</surname>
                <given-names>EV</given-names>
              </name>
              <name>
                <surname>McKenzie</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Forrester</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bouzekri</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Harding</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Serjeant</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Peto</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Weatherall</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>UGT1A1 variation and gallstone formation in sickle cell disease.</article-title>
            <source>Blood</source>
            <year>2005</year>
            <month>Feb</month>
            <day>01</day>
            <volume>105</volume>
            <issue>3</issue>
            <fpage>968</fpage>
            <page-range>968-72</page-range>
            <pub-id pub-id-type="pmid">15388579</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Murphy</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Bryzman</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Glynn</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Ameti</surname>
                <given-names>DI</given-names>
              </name>
              <name>
                <surname>Thomson</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Nass</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Ownby</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Schreiber</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Kong</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Neal</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Nemo</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS).</article-title>
            <source>Hepatology</source>
            <year>2000</year>
            <month>Mar</month>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>756</fpage>
            <page-range>756-62</page-range>
            <pub-id pub-id-type="pmid">10706569</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ott</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Stevens</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Groeger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wiersma</surname>
                <given-names>ST</given-names>
              </name>
            </person-group>
            <article-title>Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity.</article-title>
            <source>Vaccine</source>
            <year>2012</year>
            <month>Mar</month>
            <day>09</day>
            <volume>30</volume>
            <issue>12</issue>
            <fpage>2212</fpage>
            <page-range>2212-9</page-range>
            <pub-id pub-id-type="pmid">22273662</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fischer</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Goltz</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>[Autoimmune liver diseases].</article-title>
            <source>Pathologe</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>41</volume>
            <issue>5</issue>
            <fpage>444</fpage>
            <page-range>444-456</page-range>
            <pub-id pub-id-type="pmid">32749523</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vierling</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Berk</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Hofmann</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Wolkoff</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Scharschmidt</surname>
                <given-names>BF</given-names>
              </name>
            </person-group>
            <article-title>Normal fasting-state levels of serum cholyl-conjugated bile acids in Gilbert's syndrome: an aid to the diagnosis.</article-title>
            <source>Hepatology</source>
            <year>1982</year>
            <season>May-Jun</season>
            <volume>2</volume>
            <issue>3</issue>
            <fpage>340</fpage>
            <page-range>340-3</page-range>
            <pub-id pub-id-type="pmid">7076117</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Douglas</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Beckett</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Nimmo</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Finlayson</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Percy-Robb</surname>
                <given-names>IW</given-names>
              </name>
            </person-group>
            <article-title>Bile salt measurements in Gilbert's syndrome.</article-title>
            <source>Eur J Clin Invest</source>
            <year>1981</year>
            <month>Dec</month>
            <volume>11</volume>
            <issue>6</issue>
            <fpage>421</fpage>
            <page-range>421-3</page-range>
            <pub-id pub-id-type="pmid">6800816</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Okolicsanyi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fevery</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Billing</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Berthelot</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Schmid</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Berk</surname>
                <given-names>PD</given-names>
              </name>
            </person-group>
            <article-title>How should mild, isolated unconjugated hyperbilirubinemia be investigated?</article-title>
            <source>Semin Liver Dis</source>
            <year>1983</year>
            <month>Feb</month>
            <volume>3</volume>
            <issue>1</issue>
            <fpage>36</fpage>
            <page-range>36-41</page-range>
            <pub-id pub-id-type="pmid">6340206</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klevens</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Iqbal</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rizzo</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Hanson</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sweet</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Phan</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Cronquist</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Khudyakov</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xia</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Spradling</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>The evolving epidemiology of hepatitis a in the United States: incidence and molecular epidemiology from population-based surveillance, 2005-2007.</article-title>
            <source>Arch Intern Med</source>
            <year>2010</year>
            <month>Nov</month>
            <day>08</day>
            <volume>170</volume>
            <issue>20</issue>
            <fpage>1811</fpage>
            <page-range>1811-8</page-range>
            <pub-id pub-id-type="pmid">21059974</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodriguez-Castro</surname>
                <given-names>KI</given-names>
              </name>
              <name>
                <surname>Hevia-Urrutia</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Sturniolo</surname>
                <given-names>GC</given-names>
              </name>
            </person-group>
            <article-title>Wilson's disease: A review of what we have learned.</article-title>
            <source>World J Hepatol</source>
            <year>2015</year>
            <month>Dec</month>
            <day>18</day>
            <volume>7</volume>
            <issue>29</issue>
            <fpage>2859</fpage>
            <page-range>2859-70</page-range>
            <pub-id pub-id-type="pmid">26692151</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>McAllister</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Teckman</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Alpha-1 antitrypsin deficiency liver disease.</article-title>
            <source>Transl Gastroenterol Hepatol</source>
            <year>2021</year>
            <volume>6</volume>
            <fpage>23</fpage>
            <pub-id pub-id-type="pmid">33824927</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fargo</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Grogan</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Saguil</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of Jaundice in Adults.</article-title>
            <source>Am Fam Physician</source>
            <year>2017</year>
            <month>Feb</month>
            <day>01</day>
            <volume>95</volume>
            <issue>3</issue>
            <fpage>164</fpage>
            <page-range>164-168</page-range>
            <pub-id pub-id-type="pmid">28145671</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ullrich</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sieg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Blume</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bock</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Schr&#x000f6;ter</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bircher</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Normal pathways for glucuronidation, sulphation and oxidation of paracetamol in Gilbert's syndrome.</article-title>
            <source>Eur J Clin Invest</source>
            <year>1987</year>
            <month>Jun</month>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>237</fpage>
            <page-range>237-40</page-range>
            <pub-id pub-id-type="pmid">3113968</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22249.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>VanWagner</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Evaluating elevated bilirubin levels in asymptomatic adults.</article-title>
            <source>JAMA</source>
            <year>2015</year>
            <month>Feb</month>
            <day>03</day>
            <volume>313</volume>
            <issue>5</issue>
            <fpage>516</fpage>
            <page-range>516-7</page-range>
            <pub-id pub-id-type="pmid">25647209</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
